Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease
Clinical trial NCT02339415 · COMPLETED
Trial details
- NCT number
- NCT02339415
- Sponsor
- Hennepin Healthcare Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-09-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.